Literature DB >> 30144986

Infection Control in Teeth with Apical Periodontitis Using a Triple Antibiotic Solution or Calcium Hydroxide with Chlorhexidine: A Randomized Clinical Trial.

Marcia E F Arruda1, Mônica A S Neves2, Anibal Diogenes3, Ibrahimu Mdala4, Bianca P S Guilherme1, José F Siqueira1, Isabela N Rôças1.   

Abstract

INTRODUCTION: This randomized clinical study compared the antibacterial effectiveness of treatment protocols using either a triple antibiotic solution (1 mg/mL) or calcium hydroxide/chlorhexidine paste as interappointment medication in infected canals of teeth with primary apical periodontitis.
METHODS: The root canals of single-rooted teeth with apical periodontitis were prepared by using a reciprocating single-instrument technique with 2.5% sodium hypochlorite irrigation and then medicated for 1 week with either a triple antibiotic solution (minocycline, metronidazole, and ciprofloxacin) at 1 mg/mL (n = 24) or a calcium hydroxide paste in 2% chlorhexidine gluconate (n = 23). Samples were taken from the canal at the baseline (S1), after chemomechanical preparation (S2), and after intracanal medication (S3). DNA extracts from clinical samples were evaluated for total bacterial reduction using a 16S ribosomal RNA gene-based quantitative polymerase chain reaction assay.
RESULTS: All S1 samples were positive for the presence of bacteria, and counts were substantially reduced after treatment procedures (P < .01). Bacterial levels in S2 and S3 samples did not significantly differ between groups (P > .05). S2 to S3 reduction was 97% in the antibiotic group and 39% in the calcium hydroxide/chlorhexidine group; only the former reached statistical significance (P < .01). There were significantly more quantitative polymerase chain reaction-negative S3 samples in the antibiotic group than in the calcium hydroxide group (P < .05).
CONCLUSIONS: Interappointment medication with a triple antibiotic solution at the concentration of 1 mg/mL significantly improved root canal disinfection, and its effects were at least comparable with the calcium hydroxide/chlorhexidine paste. Effectiveness and easy delivery of the antibiotic solution make it an appropriate medicament as part of a disinfecting protocol for conventional nonsurgical endodontic treatment and possibly regenerative endodontic procedures.
Copyright © 2018 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apical periodontitis; calcium hydroxide; endodontic treatment; triple antibiotic mixture

Mesh:

Substances:

Year:  2018        PMID: 30144986     DOI: 10.1016/j.joen.2018.07.001

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  5 in total

1.  Antimicrobial Effects of L-Chg10-Teixobactin against Enterococcus faecalis In Vitro.

Authors:  Alaa Jarkhi; Angeline Hui Cheng Lee; Zhenquan Sun; Mingxin Hu; Prasanna Neelakantan; Xuechen Li; Chengfei Zhang
Journal:  Microorganisms       Date:  2022-05-26

2.  Effect of Different Intracanal Medicaments on the Viability and Survival of Dental Pulp Stem Cells.

Authors:  Shilpa Bhandi; Shankargouda Patil; Nezar Boreak; Hitesh Chohan; Abdulaziz S AbuMelha; Mazen F Alkahtany; Khalid H Almadi; Thilla Sekar Vinothkumar; A Thirumal Raj; Luca Testarelli
Journal:  J Pers Med       Date:  2022-04-04

Review 3.  Antimicrobial Therapeutics in Regenerative Endodontics: A Scoping Review.

Authors:  Juliana S Ribeiro; Eliseu A Münchow; Ester A Ferreira Bordini; Wellington Luiz de Oliveira da Rosa; Marco C Bottino
Journal:  J Endod       Date:  2020-09       Impact factor: 4.171

4.  Antimicrobial Efficacy of Intracanal Medicaments against E. Faecalis Bacteria in Infected Primary Molars by Using Real-Time PCR: A Randomized Clinical Trial.

Authors:  Yasamin Ghahramani; Najmeh Mohammadi; Ahmad Gholami; Dordaneh Ghaffaripour
Journal:  Int J Dent       Date:  2020-12-21

5.  Comparison of Local and Systemic Ibuprofen for Relief of Postoperative Pain in Symptomatic Teeth with Apical Periodontitis.

Authors:  İbrahim Uysal; Veysel Eratilla; Celalettin Topbaş; İsmail Ergül; Yusuf Çelik
Journal:  Med Sci Monit       Date:  2022-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.